ACELYRIN, INC. to Present at Upcoming Investor Conferences

LOS ANGELES, Nov. 3, 2022 /PRNewswire/ -- ACELYRIN, INC., a late-stage biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that its Co-founder and Chief Executive Officer Shao-Lee Lin, MD, PhD will present at...

Click to view original post